The 13-valent refers to the 13-valent pneumococcal polysaccharide conjugate vaccine, and there are no data to support the probability of fever after receiving this vaccine, so it is not yet possible to tell.
The 13-valent pneumococcal polysaccharide conjugate vaccine is used for active immunization of infants and young children against invasive disease caused by pneumococcal serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F.
After vaccination, patients may experience adverse reactions such as fever, swelling and pain at the injection site, decreased appetite, increased or decreased sleep, and nervousness and irritability, which usually disappear on their own. Due to the different physical condition of individuals, there are individual differences in the probability of fever, so it is not yet possible to determine the specific value.
It should be noted that it is forbidden for those who are allergic to any active ingredients, excipients or diphtheria toxoid in this product. Patients are advised to go to regular hospitals and be vaccinated under the correct operation of doctors.